Jean‐Pierre Hallé

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

P. Raskin, Leslie J. Klaff, Richard M. Bergenstal et al. · Diabetes Care · 2000 · 251 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Production of alginate beads by emulsification/internal gelation. I. Methodology

Denis Poncelet, Robert W. Lencki, Claudie Beaulieu et al. · Applied Microbiology and Biotechnology · 1992 · 233 citations

Engineering, Biological Engineering, Manufacturing Engineering +11

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

Yves Lacourciére, André Bélanger, Chantal Godin et al. · Kidney International · 2000 · 229 citations · Full text

Medicine, Nephrology, Pharmacotherapy +13